Bleomycin-induced flagellate hyperpigmentation
Main Author: | |
---|---|
Publication Date: | 2013 |
Other Authors: | , , |
Format: | Article |
Language: | eng |
Source: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Download full: | http://hdl.handle.net/10400.23/428 |
Summary: | Bleomycin is a chemotherapeutic agent used in the treatment of different tumours. It has several side effects, including flagellate hyperpigmentation, which is a unique and a well-documented side effect of bleomycin therapy. We report a case of a 23-year-old woman with a personal history of ovarian dysgerminoma, who developed flagellate hyperpigmentation on trunk after bleomycin therapy. |
id |
RCAP_d1ceafd3d2cca89aed65594185603735 |
---|---|
oai_identifier_str |
oai:repositorio.hospitaldebraga.pt:10400.23/428 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Bleomycin-induced flagellate hyperpigmentationAntibióticos AntineoplásicosBleomicinaErupções por MedicamentosHiperpigmentaçãoBleomycin is a chemotherapeutic agent used in the treatment of different tumours. It has several side effects, including flagellate hyperpigmentation, which is a unique and a well-documented side effect of bleomycin therapy. We report a case of a 23-year-old woman with a personal history of ovarian dysgerminoma, who developed flagellate hyperpigmentation on trunk after bleomycin therapy.BMJRepositório Científico do Hospital de BragaResende, CAraújo, CGomes, JBrito, C2013-06-21T08:25:05Z2013-01-01T00:00:00Z2013-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.23/428engBMJ Case Rep. 2013 Jun 5;2013. pii: bcr2013009745.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-21T09:02:03Zoai:repositorio.hospitaldebraga.pt:10400.23/428Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:54:56.434333Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Bleomycin-induced flagellate hyperpigmentation |
title |
Bleomycin-induced flagellate hyperpigmentation |
spellingShingle |
Bleomycin-induced flagellate hyperpigmentation Resende, C Antibióticos Antineoplásicos Bleomicina Erupções por Medicamentos Hiperpigmentação |
title_short |
Bleomycin-induced flagellate hyperpigmentation |
title_full |
Bleomycin-induced flagellate hyperpigmentation |
title_fullStr |
Bleomycin-induced flagellate hyperpigmentation |
title_full_unstemmed |
Bleomycin-induced flagellate hyperpigmentation |
title_sort |
Bleomycin-induced flagellate hyperpigmentation |
author |
Resende, C |
author_facet |
Resende, C Araújo, C Gomes, J Brito, C |
author_role |
author |
author2 |
Araújo, C Gomes, J Brito, C |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
Repositório Científico do Hospital de Braga |
dc.contributor.author.fl_str_mv |
Resende, C Araújo, C Gomes, J Brito, C |
dc.subject.por.fl_str_mv |
Antibióticos Antineoplásicos Bleomicina Erupções por Medicamentos Hiperpigmentação |
topic |
Antibióticos Antineoplásicos Bleomicina Erupções por Medicamentos Hiperpigmentação |
description |
Bleomycin is a chemotherapeutic agent used in the treatment of different tumours. It has several side effects, including flagellate hyperpigmentation, which is a unique and a well-documented side effect of bleomycin therapy. We report a case of a 23-year-old woman with a personal history of ovarian dysgerminoma, who developed flagellate hyperpigmentation on trunk after bleomycin therapy. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-06-21T08:25:05Z 2013-01-01T00:00:00Z 2013-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.23/428 |
url |
http://hdl.handle.net/10400.23/428 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
BMJ Case Rep. 2013 Jun 5;2013. pii: bcr2013009745. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
BMJ |
publisher.none.fl_str_mv |
BMJ |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130416793255936 |